THAHLAN TERMINAL

Live U.S. market intelligence

Official data from the SEC, FDA, U.S. Treasury, Federal Reserve and Bureau of Labor Statistics, filtered for what moves markets and updated automatically.

US ECONOMIC CALENDARNYC

    Official schedules: Federal Reserve, Bureau of Labor Statistics, Bureau of Economic Analysis. Times are New York (ET).

    RATES & ECONOMYTREASURY.GOV ↗
    1. …
    SEC · MAJOR CORPORATE EVENTSSEC.GOV ↗
    1. …

    Sources: U.S. Treasury (daily par yield curve), Federal Reserve Bank of New York, Bureau of Labor Statistics, SEC EDGAR. SEC: only big news qualifies. (1) Takeover bids, sales of a company, bankruptcies, financial restatements and changes in control: any of the ~3,000 largest U.S.-listed companies. (2) Completed acquisitions and divestitures: the 500 largest. (3) Earnings: the 50 largest always; companies ranked 51–500 only if the stock moved 5% or more in the first session after the report. (4) Major agreements, restructurings and write-downs: only if the stock moved 5% or more (3% for the 50 largest). Executive and board changes are excluded. The 14 most important events are selected, then listed by exact filing time, newest first. The % shown is that first-session stock move.

    FDA · MAJOR DECISIONSFDA.GOV ↗
    1. …
    PHASE 3 TRIALS · LARGEST FIRSTCLINICALTRIALS.GOV ↗
    1. …

    FDA selection: approvals only, ranked by likely earnings impact: new drugs from large listed companies first, then first-of-a-kind approvals, other new drugs, and new uses for drugs of the 100 largest companies; generics, biosimilars, recalls and routine notices are excluded. Trials: Phase 3 studies by publicly traded companies, 500+ patients, main results due within six months, ranked largest first. Sources: FDA, openFDA, ClinicalTrials.gov.

    INSIDER TRADES · BIG MONEY ONLYSEC.GOV ↗
    1. …
    BIG INVESTORS · 13F MOVESSEC.GOV ↗
    1. …

    Insider trades: open-market purchases of $500K or more by executives, directors and 10% owners of the ~1,000 largest U.S.-listed companies, and open-market sales of $10M or more at the ~500 largest, excluding pre-scheduled 10b5-1 plan sales. The 14 most significant trades of the past two weeks are shown, newest first. 13F: quarterly holdings reported by leading investors; new positions and full exits of at least 0.3% of the portfolio, and position changes of 20% or more. 13F reports are filed up to 45 days after quarter-end. Source: SEC EDGAR.

    EARNINGS CALENDAR · $40B+ COMPANIES
    1. …
    FDA DECISION DATES (PDUFA)
    1. …

    Earnings: companies with a market value of $40 billion or more reporting in the next two weeks, with consensus earnings-per-share estimates. FDA decision dates: target action dates for major new drugs and new uses, as announced by the companies; the FDA can act early or extend a review.